Oarsman Capital’s Medpace MEDP Stock Holding History

Oarsman Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31	Closed	-$10.3K	–	596
2024 Q4	$10.3K	Hold	31	–	–	﹤0.01%	692
2024 Q3	$10.3K	Buy	+31	New	+$11.8K	﹤0.01%	702

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oarsman Capital's MEDP Position: Q1 2025 in Review

Oarsman Capital sold out of Medpace (MEDP) in Q1 2025, closing a stake of 31 shares — an estimated $10.3K sold.

Oarsman Capital first reported a position in MEDP in Q3 2024 and held it in 2 quarters. The position peaked at $10.3K in Q3 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

Oarsman Capital reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 31 Medpace shares in Q1 2025, an estimated $10.3K.
Oarsman Capital first reported a position in Medpace in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Medpace position peaked at $10.3K in Q3 2024.
586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.